Α rare case of myopathy, lactic acidosis, and severe rhabdomyolysis, due to a homozygous mutation of the ferredoxin‐2 ( FDX2 ) gene
American Journal of Medical Genetics Part A · 2023
DOI: 10.1002/ajmg.a.63368 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2023. Verfasst von Nikolaos Gkiourtzis und 4 weiteren Autor:innen. Beteiligte Einrichtung: 4th Department of Pediatrics, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Acidosis, Lactic, Muscular Diseases, Rhabdomyolysis, Mitochondrial Myopathies. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Mitochondrial myopathy is a severe metabolic myopathy related to nuclear or mitochondrial DNA dysfunction. We present a rare case of mitochondrial myopathy, presented with multiple episodes of proximal muscle weakness, lactic acidosis, and severe rhabdomyolysis (CPK 319,990 U/L, lactic acid 22.31 mmol/L, and GFR 3.82 mL/min/1.73m 2 ). She was hospitalized in the pediatric intensive care unit due to acute kidney injury, elevated blood pressure, and deterioration of respiratory and cardiac function. Investigation for inherited metabolic disorders showed elevated levels of ammonia, lactic acid to pyruvic acid ratio, and urine ketone bodies. Exome sequencing detected a homozygous pathogenic variant in FDX2 (ENST00000541276:p.Met4Leu/c.10A > T) and a heterozygous variant of uncertain significance in MSTO1 (ENST00000538143:p.Leu137Pro/c.410 T > C). After Sanger sequencing, the p.Met4Leu pathogenic variant in FDX2 (ENST00000541276:p.Met4Leu/c.10A > T) was identified in a heterozygous state in both her parents and sister. Recently, pathogenic variants in the FDX2 gene have been associated with mitochondrial myopathy, lactic acidosis, optic atrophy, and leukoencephalopathy. Only four reports of FDX2 ‐related rhabdomyolysis have been described before, but none of the previous patients had hyperammonemia. This is a rare case of severe mitochondrial myopathy in a pediatric patient related to a pathogenic FDX2 variant, suggesting the need for genetic analysis of the FDX2 gene in cases of suspicion of mitochondrial myopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 4th Department of Pediatrics, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
ORCID-Profile: Nikolaos Gkiourtzis, Despoina Tramma, Kyriaki Papadopoulou-Legbelou, Maria Moutafi, Athanasios Evangeliou
Zitieren
APA
Gkiourtzis, N., Tramma, D., Papadopoulou-Legbelou, K., Moutafi, M., & Evangeliou, A. (2023). Α rare case of myopathy, lactic acidosis, and severe rhabdomyolysis, due to a homozygous mutation of the ferredoxin‐2 ( FDX2 ) gene. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63368
Vancouver
Gkiourtzis N, Tramma D, Papadopoulou-Legbelou K, Moutafi M, Evangeliou A. Α rare case of myopathy, lactic acidosis, and severe rhabdomyolysis, due to a homozygous mutation of the ferredoxin‐2 ( FDX2 ) gene. American Journal of Medical Genetics Part A. 2023. doi:10.1002/ajmg.a.63368
BibTeX
@article{Gkiourtzis2023,
author = {Gkiourtzis, Nikolaos and Tramma, Despoina and Papadopoulou-Legbelou, Kyriaki and Moutafi, Maria and Evangeliou, Athanasios},
title = {Α rare case of myopathy, lactic acidosis, and severe rhabdomyolysis, due to a homozygous mutation of the ferredoxin‐2 ( FDX2 ) gene},
journal = {American Journal of Medical Genetics Part A},
year = {2023},
doi = {10.1002/ajmg.a.63368}
}
EUVIMED